Covid-19 roundup: Merck and Ridgeback report early data for an oral antiviral to fight the pandemic; Austria pulls a batch of AstraZeneca’s vaccine after patient death
A couple of months after scrapping its Covid-19 vaccine program, Merck has read out early data for an oral antiviral it’s developing with Ridgeback Biotherapeutics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
